sponsored by
simmons hanly conroy
a national law firm
(866) 445-2964
simmons hanly conroy
a national law firm
The U.S. Food & Drug Administration is investigating the risk of testosterone treatments causing an increased rate of cardiovascular events such as heart attacks and stroke, according to a drug safety communication from the…
read moreFDA proposes rule changes to hold generic drug manufacturers accountable for injuries The FDA has proposed new rules that would improve generic drug manufacturer accountability. More than 80 percent of prescriptions are…
read moreThe hepatitis B warnings on two blood cancer drugs were recently strengthened by the Food and Drug Administration (FDA), according to Fox News. The strengthened warnings were issued to reflect the risk of…
read moreRecently, the Food and Drug Administration (FDA) announced that the commonly used anti-malaria drug, called mefloquine hydrochloride (brand name Lariam) must have a “black box” warning on its label. The drug has…
read moreThe U.S. Food & Drug Administration has indicated it might allow generic drug manufacturers to revise their products’ safety labels independent of their name brand counterparts. If this change is made, consumers harmed by…
read more
Our dedication to customer service, our national resources, and our cumulative centuries of legal experience are what drives our results.
make an appointment
